BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  DowDuPont Reports Fourth Quarter and Full Year 2017 Results

  Sales of $2.8 billion were up 5 percent from pro forma net sales of $2.7 billion in the year-ago period.

  February 1, 2018

   · 

  65 min read
• Business

  Domainex Appoints Dr Kevin Doyle as Head of Chemistry

  Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce that Dr Kevin Doyle has been appointed Head of Chemistry with immediate effect.

  February 1, 2018

   · 

  1 min read
• BioMidwest

  Fagron Extends Pharmaceutical Ingredient Supply Chain to American Pharmaceutical Ingredients’ Customers

  Fagron was recently selected by American Pharmaceutical Ingredients to directly service API’s customers with continued supply of active ingredients for compounding.

  February 1, 2018

   · 

  2 min read
• Biotech Beach

  BD Launches New Los Angeles County Program to Equip Patients with Essential Resources for Safe Sharps Disposal

  The launch of the new BD” CARD Your Sharps” initiative provides patients with a new sharps containment device, at no cost, and directs them to the nearest sharps take-back location.

  February 1, 2018

   · 

  5 min read
• Business

  ReShape Lifesciences Reports Preliminary Fourth Quarter and Full Year 2017 Revenue

  ReShape Lifesciences announced today preliminary revenue results for the fourth quarter and year ended December 31, 2017.

  February 1, 2018

   · 

  4 min read
• Business

  West to Host Fourth-Quarter and Full-Year 2017 Conference Call

  A live broadcast of the conference call will be available at the Company’s website, www.westpharma.com, in the “Investors” section.

  February 1, 2018

   · 

  2 min read
• BioCapital

  OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies

  The RUO AMR Gene Panel u5.47 is available for infection control purposes and pharmaceutical surveillance research as a Research Use Only test for complicated urinary tract infection (cUTI).

  February 1, 2018

   · 

  3 min read
• Drug Development

  Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction

  In the study, animals treated with the Company’s non-invasive medical device one or two times per day for 28 days had significantly smaller (by 36.4%, p<0.01) infarcts versus the controls.

  February 1, 2018

   · 

  5 min read
• Pharm Country

  OncLive to Host Latest State of the Science Summit: Gastrointestinal Malignancies

  OncLive, the leading digital provider of resources and information to oncology professionals, will present the latest State of the Science Summit: Gastrointestinal Malignancies on Feb. 8 at the Hyatt Regency Bethesda in Center Bethesda, Maryland, at 5:30 p.m.

  February 1, 2018

   · 

  2 min read
• Drug Development

  Gemphire Announces Initiation of Phase IIa Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)

  The trial is part of a broader program to develop gemcabene in NAFLD/NASH.

  February 1, 2018

   · 

  14 min read